Eric Elenko

Dr. Elenko is a Partner at PureTech Ventures. Prior to joining PureTech, Dr. Elenko was a consultant with McKinsey & Company where he advised senior executives of both Fortune 500 and specialty pharmaceutical companies on a range of issues such as product licensing, mergers and acquisitions, R&D strategy, and marketing. Some of his projects at McKinsey included working on a multi-billion dollar merger, crafting a brand strategy for a blockbuster drug, and recommending both pre-clinical and approved products for licensing. Dr. Elenko did graduate work in molecular pharmacology and cell biology that resulted in several peer reviewed papers and was the recipient of NIH training grants. While a graduate student, Dr. Elenko started and served as President of the Technology Evaluation Group, LLC which performed technical due diligence for angel investors in early stage life science companies Dr. Elenko received his BA in Biology from Swarthmore College and his PhD in Biomedical Sciences from University of California, San Diego.